DuPont has acquired Innovalight. Financial terms of the acquisition were not disclosed. Innovalight is a company specializing in advanced silicon inks and process technologies that increase the efficiency of crystalline silicon solar cells.
The acquisition further strengthens DuPont's position in materials for the solar energy market, enabling a broader and more integrated photovoltaic materials and technology offering.
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.
Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.
BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
